SCHEMBL3463790

SCHEMBL3463790

CCSc1cc2c(cc1Br)OCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
PKM P14618 1/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 1/20 0.35
PSMD14 O00487 1/20 0.35
TP53 P04637 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DYRK3 O43781 2/20 0.35
PIM1 P11309 2/20 0.35
DYRK1A Q13627 2/20 0.35
DYRK2 Q92630 2/20 0.35
DYRK1B Q9Y463 2/20 0.35
CSNK2A2 P19784 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3465193 0.79 SMN1; SMN2 (0.37) ALDH1A1HPGDPKMMAPTMEN1
SCHEMBL8433655 0.72 CYP1A2 (0.43) ALDH1A1HPGDPKMMAPTL3MBTL1
SCHEMBL1751672 0.72 AHR (0.53) ALDH1A1HPGDPKMMAPTHTT
SCHEMBL3464742 0.68 ALDH1A1 (0.48) ALDH1A1HPGDMAPTL3MBTL1MEN1
SCHEMBL4594563 0.67 ALDH1A1 (0.42) ALDH1A1PKMMAPTMEN1KMT2A
SCHEMBL10414208 0.67 POLB (0.38) ALDH1A1MAPTL3MBTL1MEN1KMT2A
SCHEMBL10068285 0.67 MAPT (0.40) ALDH1A1HPGDPKMMAPTHTT
SCHEMBL3465416 0.67 IGF1R (0.45) ALDH1A1HPGDMAPTHSD17B10L3MBTL1
SCHEMBL1520657 0.66 CYP3A4 (0.44) ALDH1A1HPGDMEN1KMT2AHSP90AA1
SCHEMBL11182069 0.64 CYP3A4 (0.43) ALDH1A1HPGDMAPTHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS ORYZON GENOMICS, S.A. (ES) 2010-09-23 US disclosed
EP-2183221-A1 NEW COMPOUNDS AS HSP90 INHIBITORS Crystax Pharmaceuticals S.L. (ES) 2010-05-12 EP disclosed
WO-2009007399-A1 NEW COMPOUNDS AS HSP90 INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS HSP90AB1, HSP90AB2P, HSP90AA1 ALDH1A1 1875/4885HPGD 925/4885PKM 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.